ArticleBMC health services research2025

Correction: Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis.

Mehdi Rezaee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.